Back to User profile » Dr Yi Cheng
Papers published by Dr Yi Cheng:
Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer
Ren T, Shan J, Li M, Qing Y, Qian C, Wang G, Li Q, Lu G, Li C, Peng Y, Luo H, Zhang S, Yang Y, Cheng Y, Wang D, Zhou SF
Drug Design, Development and Therapy 2015, 9:2887-2910
Published Date: 8 June 2015
Functional analysis of tanshinone IIA that blocks the redox function of human apurinic/apyrimidinic endonuclease 1/redox factor-1
Sui J, Li M, Qian C, Wang S, Cheng Y, Chen BP, Wang D
Drug Design, Development and Therapy 2014, 8:2147-2160
Published Date: 3 November 2014
Identification of a novel potential antitumor activity of gossypol as an APE1/Ref-1 inhibitor
Qian CY, Li MX, Sui JD, Ren T, Li Z, Zhang L, Zhou LW, Cheng Y, Wang D
Drug Design, Development and Therapy 2014, 8:485-496
Published Date: 9 May 2014